Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
The internet was outraged earlier this month after a new report revealed the sugar industry paid...
- Zika, dengue, chikungunya: As if there weren't enough mosquito-borne viruses to worry about, researchers say...
Gonorrhea appears to be developing resistance to the two antibiotics that constitute the last available treatment...
Even with drastic decreases in the number of Americans who smoke, four out of ten children...
